
Biocon Limited has informed the Exchange regarding a press release dated July 05, 2023, titled "Biocon Biologics Expands Footprint in Emerging Markets; Takes Over the Commercialization of Biosimilars Business from Viatris in 70+ countries".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated July 05, 2023, titled "Biocon Biologics Expands Footprint in Emerging Markets; Takes Over the Commercialization of Biosimilars Business from Viatris in 70+ countries".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon